Biogen Pharmachem Industries Ltd
Incorporated in 1995, Biogen Pharmachem Ltd is in the business of trading in shares and securities in present and future market.
- Market Cap ₹ 64.6 Cr.
- Current Price ₹ 0.99
- High / Low ₹ 1.76 / 0.92
- Stock P/E
- Book Value ₹ 0.85
- Dividend Yield 0.00 %
- ROCE 0.65 %
- ROE 0.61 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Stock is trading at 1.17 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -3.62% over past five years.
- Company has a low return on equity of 0.08% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.95 | 0.00 | 1.62 | 2.47 | 0.00 | 0.79 | 0.69 | |
0.04 | 0.03 | 0.04 | 0.03 | 0.12 | 6.72 | 0.95 | 0.12 | 3.22 | 2.49 | 0.45 | 0.43 | 1.00 | |
Operating Profit | -0.04 | -0.03 | -0.04 | -0.03 | -0.12 | -6.61 | 0.00 | -0.12 | -1.60 | -0.02 | -0.45 | 0.36 | -0.31 |
OPM % | -6,009.09% | 0.00% | -98.77% | -0.81% | 45.57% | -44.93% | |||||||
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 | 0.01 | 0.91 | 1.59 | -0.42 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
Depreciation | 0.10 | 0.10 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | -0.14 | -0.13 | -0.14 | -0.03 | -0.12 | -6.56 | 0.00 | -0.12 | -1.60 | -0.01 | 0.46 | 1.93 | -0.73 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
-0.13 | -0.13 | -0.13 | -0.03 | -0.12 | -6.56 | 0.00 | -0.12 | -1.60 | -0.01 | 0.46 | 1.93 | -0.73 | |
EPS in Rs | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.10 | 0.00 | -0.00 | -0.02 | -0.00 | 0.01 | 0.03 | -0.01 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | -4% |
3 Years: | -21% |
TTM: | -7% |
Compounded Profit Growth | |
---|---|
10 Years: | 17% |
5 Years: | % |
3 Years: | 30% |
TTM: | -174% |
Stock Price CAGR | |
---|---|
10 Years: | 16% |
5 Years: | 39% |
3 Years: | -16% |
1 Year: | -4% |
Return on Equity | |
---|---|
10 Years: | -1% |
5 Years: | -1% |
3 Years: | 0% |
Last Year: | 1% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 |
Reserves | -4.01 | -4.14 | -4.27 | -4.30 | -4.42 | -10.98 | -10.99 | -9.51 | -11.12 | -11.13 | -10.67 | -8.74 | -9.90 |
0.00 | 57.21 | 10.00 | 6.21 | 0.72 | 0.01 | 0.63 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
3.89 | 4.93 | 2.49 | 1.64 | 1.69 | 1.64 | 2.73 | 0.03 | 0.11 | 0.82 | 0.24 | 0.30 | 0.10 | |
Total Liabilities | 65.14 | 123.26 | 73.48 | 68.81 | 63.25 | 55.93 | 57.63 | 56.09 | 54.25 | 54.95 | 54.83 | 56.82 | 55.46 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 51.87 | 60.86 | 43.78 | 26.69 | 22.39 | 3.52 | 6.25 | 6.45 | 9.49 | 6.95 | 8.85 | 5.44 | 2.73 |
13.27 | 62.40 | 29.70 | 42.12 | 40.86 | 52.41 | 51.38 | 49.64 | 44.76 | 48.00 | 45.98 | 51.38 | 52.73 | |
Total Assets | 65.14 | 123.26 | 73.48 | 68.81 | 63.25 | 55.93 | 57.63 | 56.09 | 54.25 | 54.95 | 54.83 | 56.82 | 55.46 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.05 | -7.28 | 4.68 | -0.07 | -13.65 | 0.09 | -1.21 | 3.95 | 1.40 | 1.70 | 1.94 | |
0.00 | -8.99 | 17.08 | 17.08 | 4.30 | 14.32 | -0.72 | 1.54 | -3.64 | -1.32 | -1.66 | -2.06 | |
0.00 | 10.33 | -11.19 | -21.74 | -4.31 | -0.71 | 0.62 | -0.32 | -0.31 | 0.00 | 0.00 | 0.00 | |
Net Cash Flow | 0.00 | 1.39 | -1.38 | 0.02 | -0.07 | -0.03 | -0.02 | 0.00 | 0.00 | 0.08 | 0.05 | -0.11 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 23,326.82 | 3,085.21 | 572.28 | 0.00 | 0.00 | |||||||
Inventory Days | 0.00 | 0.00 | 0.00 | |||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 23,326.82 | 3,085.21 | 572.28 | 0.00 | 0.00 | |||||||
Working Capital Days | 23,194.09 | 2,651.05 | 549.75 | 152.21 | -106.27 | |||||||
ROCE % | -0.22% | -0.14% | -0.15% | -0.04% | -0.19% | -11.32% | 0.00% | -0.22% | -2.90% | -0.02% | -0.37% | 0.65% |
Documents
Announcements
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Today 11.03.2025 - Preferential Allotment Of Equity Warrants
2d - Allotment of 25 crore equity share warrants to non-promoters.
-
Updation Of Website Of The Company On Corporate Information
8 Mar - Update of company website as per regulations.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Today 07.03.2025 - Preferential Allotment Of Equity Warrants
7 Mar - Board approved allotment of 25 crore equity share warrants.
-
Integrated Filing (Financial)
5 Feb - Integrated financial filing for Q3 and nine months ended December 2024.
-
Pursuant To Second Proviso To Regulation 30(6) And Regulation 33 Of The SEBI (Listing
Obligations And Disclosure Requirements) Regulations, 2015 We Hereby Inform You That The
Board Of The Company, In Their Meeting Held On Today I.E. Wednesday 5Th February
2025 At The Registered Office Of The Company And Transacted The Following Major Businesses:
5 Feb - Board meeting results including financials and director changes.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
Company used to deal in shares and securities and traded in commodities including agro based and precious metals and other goods in present and future markets